Based on our study of low- and intermediate-risk PCa, we found patients with both a positive mpMRI and 68Ga-PSMA PET/CT indicated the possible necessity for a prostate biopsy [35]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.